Menjugate
RSRSG 12-03
Approved mab completed
Quick answer
Menjugate for Meningococcal Disease is a Approved program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Meningococcal Disease
- Phase
- Approved
- Modality
- mab
- Status
- completed